Get In Touch

COVID-19 Test Home Collection Kits Gain Popularity in Middle East and Africa

Since the U.S. Food and Drug Administration (FDA) authorized LabCorp’s Pixel COVID-19 Test Home Collection Kit, companies in the MEA direct-to-consumer laboratory testing market are taking cues from the same. Manufacturers are developing COVID-19 test home collection kits that can be used by individuals of 18 years and above without the need for a prescription. Such kits are allowing users to self-collect a nasal swab sample at home and then send that sample for testing to labs.

Companies in the MEA direct-to-consumer laboratory testing market are innovating in COVID-19 test home collection kits that enable positive or invalid results that are delivered to the user by phone call from a healthcare provider or a lab.

mea direct to consumer laboratory testing market infographic

Request a sample to get extensive insights into the Direct-to-Consumer Laboratory Testing Market

Lack of Regulations for Genetic DTC Testing Affects Market Growth

The MEA direct-to-consumer laboratory testing market is expected to expand at a CAGR of 18.3% during the forecast period. The cost of gene sequencing is decreasing due to advancements in next gen sequencing (NGS) and increasing availability of direct-to-consumer (DTC) laboratory testing. However, it has been found that in many cases, DTC tests are not regulated by the government healthcare organizations. Hence, healthcare companies and healthcare authorities should collaborate to implement regulations regarding DTC, and create awareness about the key differences and limitations between clinical & DTC genetic tests.

Manufacturers are increasing R&D in low cost and automated tests with automated analysis and reporting.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Companies Pursuing Opportunities in DTC Testing Due to Growth in Telehealth

The surge in the demand for DTC testing is part of a broader shift toward telehealth and eCommerce as a result of the ongoing coronavirus pandemic. Virtual care is likely to surge in the upcoming years, since weekly visits are growing at a substantial rate. Market stakeholders are setting their collaboration wheels in motion to sell new COVID-19 home sample collection kits.

Stakeholders in the MEA direct-to-consumer laboratory testing market are scaling up testing and telehealth services due to the ongoing pandemic. They have been working at break-neck speed to meet the unprecedented demand for COVID-19 home sample collection kits. Healthcare companies are expanding their marketing strategy spanning from podcosts to news channels to increase acceptance of DTC operations.

DTC Genetic Testing Enabling Access to Information on Risks of Cancer

Personalized, precision, and genomic medicines based on DNA sequencing hold potentials to offer opportunities for improving the overall public health. The MEA direct-to-consumer laboratory testing market is undergoing a significant change with DNA sequencing being applied for disease prevention such as heart diseases, cancers, and metabolic diseases.

The identification of patients’ risk profile is becoming necessary in the MEA direct-to-consumer laboratory testing market. This is explains why the market is anticipated to reach US$ 928.34 Mn by 2031. DTC genetic testing (DTCGT) is allowing access to information on their risks of suffering from a wide range of chronic diseases.

Patient-centered Patient Care Creating Revenue Opportunities for Stakeholders

Telehealth is making it possible for increasing the availability of direct-to-consumer laboratory testing. Patient-centered laboratory stewardship is acting as a key driver for the MEA direct-to-consumer laboratory testing market. There is a growing need for patient care that is respectful of and responsive to individual patient preferences, values, and needs. These trends are ensuring that patient values guide all clinical decisions.

The concept of patient centered capitalism is storming the MEA direct-to-consumer laboratory testing market. Stakeholders are prioritizing the interests of patients over those of financial and other stakeholders within both the healthcare system & its suppliers. Patient-centered laboratory stewardship is proving beneficial to improve important areas of lab testing and DTC testing such as test ordering, result retrieval, result interpretation, and financial fairness for patients and other stakeholders.

mea direct to consumer laboratory testing market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Direct-to-Consumer Laboratory Testing Market

Analysts’ Viewpoint

With the COVID-19 pandemic accelerating interest in telehealth and consumer-initiated testing, companies in the MEA direct-to-consumer laboratory testing market are aiming to expand their DTC operations. DTC genetic testing aimed at guiding a patient’s diet or exercise remains largely unproven in producing better outcomes. Hence, market stakeholders should collaborate and implement laboratory stewardship programs that put in safeguards to improve patient-centered care.

Genetic counseling sessions are being conducted to explain details and options at appropriate education levels. Mobile apps are being developed to facilitate patient retrieval of results. Healthcare providers in the MEA direct-to-consumer laboratory testing market are increasing patient access to their electronic medical records. Moreover, educational materials are being written in patient’s language of choice. Enhanced communication between patients and physicians through text, phone, and electronic medical record is helping to improve patient quality of life.

Middle East & Africa Direct-to-Consumer Laboratory Testing Market: Overview

  • This report analyzes the current scenario and future prospects of the direct-to-consumer laboratory testing market in MEA. Direct-to-consumer laboratory testing, also known as direct access testing, allows patients to order tests directly from a lab without having to go through a healthcare professional. These test results can be used to track current health condition, diagnose a previously undiagnosed medical condition, or provide information on personal health traits. In line with the rise in demand for quick, affordable, and accurate tests, several companies have considered offering actionable recommendations to complement the test results. This approach induces customers to seek personalized services and maximizes customer satisfaction.
  • The report includes an elaborate executive summary, which provides a snapshot of various segments and sub-segments of the direct-to-consumer laboratory testing market in MEA. It also provides information and data analysis of the direct-to-consumer laboratory testing market in MEA about segments based on test type, sample type, provider, and country/sub-region.
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the direct-to-consumer laboratory testing market in MEA
  • The report includes company profiles, which provide information about their business, product portfolios, strategic overview, and competitive landscape in the direct-to-consumer laboratory testing market in MEA
  • The report on the direct-to-consumer laboratory testing market in MEA offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the direct-to-consumer laboratory testing market in MEA. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the direct-to-consumer laboratory testing market in MEA.

Middle East & Africa Direct-to-Consumer Laboratory Testing Market: Key Segments

  • In terms of test type, the direct-to-consumer laboratory testing market in MEA has been classified into genetic testing, disease risk assessment testing, CBC, chronic disease testing, COVID-19 testing, TSH testing, and others. The genetic testing segment has been split into nutrigenetics test, celiac disease test, sports & physical activity testing, men's health tests, women's health tests, pregnancy & prenatal screening, general health testing, and others. The nutrigenetics test sub-segment has been segregated into weight control, lactose intolerance, and others. The disease risk assessment testing segment has been categorized into sexual health tests, cancer predisposition tests, and others. The sexual health tests sub-segment has been split into HIV, chlamydia, and others. The chronic disease testing segment has been segregated into diabetes testing, hypertension, and others.
  • Based on sample type, the direct-to-consumer laboratory testing market in MEA has been categorized into blood, saliva, urine, and others
  • In terms of provider, the direct-to-consumer laboratory testing market in MEA has been divided into hospitals, clinics, specialty labs, and diagnostic centers
  • Market size and forecast for each of these segments and sub-segments have been provided from 2017 to 2031. The CAGR of respective segment has also been provided from 2021 to 2031, considering 2020 as the base year, and 2017, 2018, and 2019 as historical years.

Middle East & Africa Direct-to-Consumer Laboratory Testing Market: Regional Outlook

  • In terms of country/sub-region, the direct-to-consumer laboratory testing market in MEA has been segmented into GCC Countries, South Africa, and Rest of MEA
  • The direct-to-consumer laboratory testing market report provides size and forecast for each sub-region from 2017 to 2031. The CAGR for each of these sub-regions has also been provided for the forecast period from 2021 to 2031. The direct-to-consumer laboratory testing market study covers the competitive scenario in these sub-regions.

Companies Covered in Middle East & Africa Direct-to-Consumer Laboratory Testing Market Report

  • Key players in the direct-to-consumer laboratory testing market in MEA have been profiled based on attributes such as company overview, product portfolio, financial overview, strategic overview, recent developments, and competitive business strategies
  • Major companies profiled in the direct-to-consumer laboratory testing market report are
    • 23andMe, Inc.
    • Ancestry
    • CircleDNA
    • Eurofins Scientific
    • Family Tree DNA (Gene by Gene)
    • Laboratory Corporation of America Holdings
    • Living DNA Ltd.
    • Medichecks.com Ltd.
    • MyHeritage Ltd.
    • MyMedLab, Inc.
    • Quest Diagnostics Incorporated

Middle East & Africa Direct-to-Consumer Laboratory Testing Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 124.40 Mn

Market Forecast Value in 2031

US$ 928.34 Mn

Growth Rate (CAGR)

18.3%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis at MEA as well as sub-region level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key industry events, etc.

Competition Landscape

Market share analysis by company (2020)

Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, key financials, etc.

Format

Electronic (PDF) + Excel

Market Segmentation

  • Test Type
  • Genetic Testing
    • Nutrigenetics Test
      • Weight Control
      • Lactose Intolerance
      • Others
    • Celiac Disease Test
    • Sports and Physical Activity Testing
    • Men's Health Tests
    • Women's Health Tests
    • Pregnancy and Prenatal Screening
    • General Health Testing
    • Others
  • Disease Risk Assessment Testing
    • Sexual Health Tests
      • HIV
      • Chlamydia
      • Others
    • Cancer Predisposition Tests
    • Others
  • CBC
  • Chronic Disease Testing
    • Diabetes Testing
    • Hypertension
    • Others
  • COVID-19 Testing
  • TSH Testing
  • Others
  • Sample Type
  • Blood
  • Saliva
  • Urine
  • Others
  • Provider
  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centers

Regions Covered

MEA

 

GCC Countries

South Africa

Rest of MEA

Companies Profiled

23andMe, Inc.

Ancestry

CircleDNA

Eurofins Scientific

Family Tree DNA (Gene by Gene)

Laboratory Corporation of America Holdings

Living DNA Ltd.

Medichecks.com Ltd.

MyHeritage Ltd.

MyMedLab, Inc.

Quest Diagnostics Incorporated

Customization Scope

Available upon request

Pricing

Available upon request

Middle East & Africa Direct-to-Consumer Laboratory Testing Market – Scope of Report

TMR’s report on the direct-to-consumer laboratory testing market in Middle East & Africa studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the direct-to-consumer laboratory testing market in MEA for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the direct-to-consumer laboratory testing market in MEA for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the direct-to-consumer laboratory testing market in MEA.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomena in the direct-to-consumer laboratory testing market in MEA.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the direct-to-consumer laboratory testing market in MEA. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the direct-to-consumer laboratory testing market in MEA. The next section of the direct-to-consumer laboratory testing market report highlights the USPs such as key industrial events (licensing partnership/merger & acquisition), disease epidemiology by region/ country/sub-region, COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact), and key success factors of top players operating in the direct-to-consumer laboratory testing market in MEA.

The report also delves into the competition landscape of the direct-to-consumer laboratory testing market in MEA. Key players operating in the direct-to-consumer laboratory testing market in MEA have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, strategic overview, and SWOT are some of the attributes of players in the direct-to-consumer laboratory testing market in MEA profiled in this report.

Key Questions Answered in Middle East & Africa Direct-to-Consumer Laboratory Testing Market Report

  • What are the major drivers, restraints, and opportunities in the market?
  • What are the revenue share projections of key segments of the direct-to-consumer laboratory testing market in MEA during the forecast period?
  • Which segment is likely to lead the direct-to-consumer laboratory testing market in MEA in terms of revenue by 2031?
  • How technological developments are widening the scope for the direct-to-consumer laboratory testing market in MEA?
  • What is the market position of different companies operating in the direct-to-consumer laboratory testing market in in MEA?

Middle East & Africa Direct-to-Consumer Laboratory Testing Market – Research Objectives and Research Approach

The comprehensive report on the direct-to-consumer laboratory testing market in MEA begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind the study and healthcare compliances laid down by accredited agencies in the purview of research in the direct-to-consumer laboratory testing market in MEA. It is followed by market introduction, market dynamics, and an overview of the direct-to-consumer laboratory testing market in MEA, which includes TMR analysis of market drivers, restraints, and opportunities affecting the growth of the direct-to-consumer laboratory testing market in MEA. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the direct-to-consumer laboratory testing market in MEA.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the direct-to-consumer laboratory testing market in MEA in terms of test type, sample type, provider, and country/sub-region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the direct-to-consumer laboratory testing market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Middle East & Africa Direct-to-Consumer Laboratory Testing Market – Segmentation

Test Type
  • Genetic Testing
    • Nutrigenetics Test
      • Weight Control
      • Lactose Intolerance
      • Others
    • Celiac Disease Test
    • Sports & Physical Activity Testing
    • Men's Health Tests
    • Women's Health Tests
    • Pregnancy & Prenatal Screening
    • General Health Testing
    • Others
  • Disease Risk Assessment Testing
    • Sexual Health Tests
      • HIV
      • Chlamydia
      • Others
    • Cancer Predisposition Tests
    • Others
  • CBC
  • Chronic Disease Testing
    • Diabetes Testing
    • Hypertension
    • Others
  • COVID-19 Testing
  • TSH Testing
  • Others
Sample Type
  • Blood
  • Saliva
  • Urine
  • Others
Provider
  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centers
Country/Sub-region
  • GCC Countries
  • South Africa
  • Rest of MEA

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: MEA Direct-to-Consumer Laboratory Testing Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key Industrial Events (licensing partnerships/mergers & acquisitions)

    5.2. Disease Prevalence & Incidence Rate

    5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Sample Type, 2017–2031

        6.3.1. Blood

        6.3.2. Urine

        6.3.3. Saliva

        6.3.4. Others

    6.4. Market Attractiveness Analysis, by Sample Type

7. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Test Type, 2017–2031

        7.3.1. Genetic Testing

            7.3.1.1. Nutrigenetics Test

                7.3.1.1.1. Weight Control

                7.3.1.1.2. Lactose Intolerance

                7.3.1.1.3. Others

            7.3.1.2. Celiac Disease Test

            7.3.1.3. Sports & Physical Activity Testing

            7.3.1.4. Men's Health Tests

            7.3.1.5. Women's Health Tests

            7.3.1.6. Pregnancy & Prenatal Screening Test

            7.3.1.7. General Health Testing

            7.3.1.8. Others

        7.3.2. Disease Risk Assessment Testing

            7.3.2.1. Sexual Health Tests

                7.3.2.1.1. HIV

                7.3.2.1.2. Chlamydia

                7.3.2.1.3. Others

            7.3.2.2. Cancer Predisposition Tests

            7.3.2.3. Others

        7.3.3. CBC

        7.3.4. Chronic Disease Testing

            7.3.4.1. Diabetes Testing

            7.3.4.2. Hypertension

            7.3.4.3. Others

        7.3.5. COVID-19 Testing

        7.3.6. TSH Testing

        7.3.7. Others

    7.4. Market Attractiveness Analysis, by Test Type

8. MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Provider

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Provider, 2017–2031

        8.3.1. Hospitals

        8.3.2. Clinics

        8.3.3. Specialty Labs

        8.3.4. Diagnostic Centers

    8.4. Market Attractiveness Analysis, by Provider

9. GCC Countries Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Sample Type, 2017–2031

        9.2.1. Blood

        9.2.2. Urine

        9.2.3. Saliva

        9.2.4. Others

    9.3. Market Value Forecast, by Test Type, 2017–2031

        9.3.1. Genetic Testing

            9.3.1.1. Nutrigenetics Test

                9.3.1.1.1. Weight Control

                9.3.1.1.2. Lactose Intolerance

                9.3.1.1.3. Others

            9.3.1.2. Celiac Disease Test

            9.3.1.3. Sports & Physical Activity Testing

            9.3.1.4. Men's Health Tests

            9.3.1.5. Women's Health Tests

            9.3.1.6. Pregnancy & Prenatal Screening Test

            9.3.1.7. General Health Testing

            9.3.1.8. Others

        9.3.2. Disease Risk Assessment Testing

            9.3.2.1. Sexual Health Tests

                9.3.2.1.1. HIV

                9.3.2.1.2. Chlamydia

                9.3.2.1.3. Others

            9.3.2.2. Cancer Predisposition Tests

            9.3.2.3. Others

        9.3.3. CBC

        9.3.4. Chronic Disease Testing

            9.3.4.1. Diabetes Testing

            9.3.4.2. Hypertension

            9.3.4.3. Others

        9.3.5. COVID-19 Testing

        9.3.6. TSH Testing

        9.3.7. Others

    9.4. Market Value Forecast, by Provider, 2017–2031

        9.4.1. Hospitals

        9.4.2. Clinics

        9.4.3. Specialty Labs

        9.4.4. Diagnostic Centers

10. South Africa Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Sample Type, 2017–2031

        10.2.1. Blood

        10.2.2. Urine

        10.2.3. Saliva

        10.2.4. Others

    10.3. Market Value Forecast, by Test Type, 2017–2031

        10.3.1. Genetic Testing

            10.3.1.1. Nutrigenetics Test

                10.3.1.1.1. Weight Control

                10.3.1.1.2. Lactose Intolerance

                10.3.1.1.3. Others

            10.3.1.2. Celiac Disease Test

            10.3.1.3. Sports & Physical Activity Testing

            10.3.1.4. Men's Health Tests

            10.3.1.5. Women's Health Tests

            10.3.1.6. Pregnancy & Prenatal Screening Test

            10.3.1.7. General Health Testing

            10.3.1.8. Others

        10.3.2. Disease Risk Assessment Testing

            10.3.2.1. Sexual Health Tests

                10.3.2.1.1. HIV

                10.3.2.1.2. Chlamydia

                10.3.2.1.3. Others

            10.3.2.2. Cancer Predisposition Tests

            10.3.2.3. Others

        10.3.3. CBC

        10.3.4. Chronic Disease Testing

            10.3.4.1. Diabetes Testing

            10.3.4.2. Hypertension

            10.3.4.3. Others

        10.3.5. COVID-110 Testing

        10.3.6. TSH Testing

        10.3.7. Others

    10.4. Market Value Forecast, by Provider, 2017–2031

        10.4.1. Hospitals

        10.4.2. Clinics

        10.4.3. Specialty Labs

        10.4.4. Diagnostic Centers

11. Rest of MEA Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Sample Type, 2017–2031

        11.2.1. Blood

        11.2.2. Urine

        11.2.3. Saliva

        11.2.4. Others

    11.3. Market Value Forecast, by Test Type, 2017–2031

        11.3.1. Genetic Testing

            11.3.1.1. Nutrigenetics Test

                11.3.1.1.1. Weight Control

                11.3.1.1.2. Lactose Intolerance

                11.3.1.1.3. Others

            11.3.1.2. Celiac Disease Test

            11.3.1.3. Sports & Physical Activity Testing

            11.3.1.4. Men's Health Tests

            11.3.1.5. Women's Health Tests

            11.3.1.6. Pregnancy & Prenatal Screening Test

            11.3.1.7. General Health Testing

            11.3.1.8. Others

        11.3.2. Disease Risk Assessment Testing

            11.3.2.1. Sexual Health Tests

                11.3.2.1.1. HIV

                11.3.2.1.2. Chlamydia

                11.3.2.1.3. Others

            11.3.2.2. Cancer Predisposition Tests

            11.3.2.3. Others

        11.3.3. CBC

        11.3.4. Chronic Disease Testing

            11.3.4.1. Diabetes Testing

            11.3.4.2. Hypertension

            11.3.4.3. Others

        11.3.5. COVID-19 Testing

        11.3.6. TSH Testing

        11.3.7. Others

    11.4. Market Value Forecast, by Provider, 2017–2031

        11.4.1. Hospitals

        11.4.2. Clinics

        11.4.3. Specialty Labs

        11.4.4. Diagnostic Centers

12. Competition Landscape

    12.1. Market Player - Competition Matrix (by tier and size of companies)

    12.2. Company Profiles

        12.2.1. 23andMe, Inc.

            12.2.1.1. Company Description

            12.2.1.2. Business Overview

            12.2.1.3. Strategic Overview

            12.2.1.4. SWOT Analysis

        12.2.2. Ancestry

            12.2.2.1. Company Description

            12.2.2.2. Business Overview

            12.2.2.3. SWOT Analysis

        12.2.3. CircleDNA

            12.2.3.1. Company Description

            12.2.3.2. Business Overview

            12.2.3.3. SWOT Analysis

        12.2.4. Eurofins Scientific

            12.2.4.1. Company Description

            12.2.4.2. Business Overview

            12.2.4.3. Financial Overview

            12.2.4.4. SWOT Analysis

        12.2.5. Family Tree DNA (Gene by Gene)

            12.2.5.1. Company Description

            12.2.5.2. Business Overview

            12.2.5.3. SWOT Analysis

        12.2.6. Laboratory Corporation of America Holdings

            12.2.6.1. Company Description

            12.2.6.2. Business Overview

            12.2.6.3. Financial Overview

            12.2.6.4. Strategic Overview

            12.2.6.5. SWOT Analysis

        12.2.7. Living DNA Ltd.

            12.2.7.1. Company Description

            12.2.7.2. Business Overview

            12.2.7.3. SWOT Analysis

        12.2.8. Medichecks.com Ltd.

            12.2.8.1. Company Description

            12.2.8.2. Business Overview

            12.2.8.3. SWOT Analysis

        12.2.9. MyHeritage Ltd.

            12.2.9.1. Company Description

            12.2.9.2. Business Overview

            12.2.9.3. SWOT Analysis

        12.2.10. MyMedLab, Inc.

            12.2.10.1. Company Description

            12.2.10.2. Business Overview

            12.2.10.3. SWOT Analysis

        12.2.11. Quest Diagnostics Incorporated

            12.2.11.1. Company Description

            12.2.11.2. Business Overview

            12.2.11.3. Financial Overview

            12.2.11.4. Strategic Overview

            12.2.11.5. SWOT Analysis

List of Tables

Table 01: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 02: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 03: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 04: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 05: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 06: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 07: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 08: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 09: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 10: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 11: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 12: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 13: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 14: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 15: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 16: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 17: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 18: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 19: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 20: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 21: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 22: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 23: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 24: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 25: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 26: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 27: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 28: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 29: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 30: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 31: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 32: Rest of MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

List of Figures

Figure 01: MEA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 02: MEA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 03: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017–2031

Figure 04: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 05: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 06: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 07: MEA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 08: MEA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 09: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Genetic Testing, 2017–2031

Figure 10: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Disease Risk Assessment Testing, 2017–2031

Figure 11: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by CBC, 2017–2031

Figure 12: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Chronic Disease Testing, 2017–2031

Figure 13: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by COVID-19 Testing, 2017–2031

Figure 14: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by TSH Testing, 2017–2031

Figure 15: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 16: MEA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 17: MEA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 18: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 19: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Clinics, 2017–2031

Figure 20: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Specialty Labs, 2017–2031

Figure 21: MEA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Diagnostic Centers, 2017–2031

Figure 22: GCC Countries Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 23: GCC Countries Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 24: GCC Countries Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 25: GCC Countries Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 26: GCC Countries Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 27: GCC Countries Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 28: GCC Countries Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 29: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 30: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 31: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 32: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 33: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 34: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 35: SOUTH AFRICA Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Middle East Africa Direct To Consumer Laboratory Testing Market